Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 1
1980 2
1982 2
1989 1
1990 2
1991 5
1992 2
1994 1
1997 5
2005 3
2007 4
2008 2
2009 2
2010 7
2011 5
2012 3
2013 9
2014 4
2015 4
2016 10
2017 13
2018 13
2019 12
2020 12
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Results by year
Filters applied: . Clear all
Page 1
Glucagon-like peptide 1 (GLP-1).
Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Müller TD, et al. Among authors: dimarchi rd. Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30. Mol Metab. 2019. PMID: 31767182 Free PMC article. Review.
Insulin structure and function.
Mayer JP, Zhang F, DiMarchi RD. Mayer JP, et al. Among authors: dimarchi rd. Biopolymers. 2007;88(5):687-713. doi: 10.1002/bip.20734. Biopolymers. 2007. PMID: 17410596 Review.
The New Biology and Pharmacology of Glucagon.
Müller TD, Finan B, Clemmensen C, DiMarchi RD, Tschöp MH. Müller TD, et al. Among authors: dimarchi rd. Physiol Rev. 2017 Apr;97(2):721-766. doi: 10.1152/physrev.00025.2016. Physiol Rev. 2017. PMID: 28275047 Free article. Review.
Targeted pharmacological therapy restores β-cell function for diabetes remission.
Sachs S, Bastidas-Ponce A, Tritschler S, Bakhti M, Böttcher A, Sánchez-Garrido MA, Tarquis-Medina M, Kleinert M, Fischer K, Jall S, Harger A, Bader E, Roscioni S, Ussar S, Feuchtinger A, Yesildag B, Neelakandhan A, Jensen CB, Cornu M, Yang B, Finan B, DiMarchi RD, Tschöp MH, Theis FJ, Hofmann SM, Müller TD, Lickert H. Sachs S, et al. Among authors: dimarchi rd. Nat Metab. 2020 Feb;2(2):192-209. doi: 10.1038/s42255-020-0171-3. Epub 2020 Feb 20. Nat Metab. 2020. PMID: 32694693
Fibroblast activation protein (FAP) as a novel metabolic target.
Sánchez-Garrido MA, Habegger KM, Clemmensen C, Holleman C, Müller TD, Perez-Tilve D, Li P, Agrawal AS, Finan B, Drucker DJ, Tschöp MH, DiMarchi RD, Kharitonenkov A. Sánchez-Garrido MA, et al. Among authors: dimarchi rd. Mol Metab. 2016 Jul 16;5(10):1015-1024. doi: 10.1016/j.molmet.2016.07.003. eCollection 2016 Oct. Mol Metab. 2016. PMID: 27689014 Free PMC article.
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.
Müller TD, Clemmensen C, Finan B, DiMarchi RD, Tschöp MH. Müller TD, et al. Among authors: dimarchi rd. Pharmacol Rev. 2018 Oct;70(4):712-746. doi: 10.1124/pr.117.014803. Pharmacol Rev. 2018. PMID: 30087160 Review.
Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
Finan B, Ma T, Ottaway N, Müller TD, Habegger KM, Heppner KM, Kirchner H, Holland J, Hembree J, Raver C, Lockie SH, Smiley DL, Gelfanov V, Yang B, Hofmann S, Bruemmer D, Drucker DJ, Pfluger PT, Perez-Tilve D, Gidda J, Vignati L, Zhang L, Hauptman JB, Lau M, Brecheisen M, Uhles S, Riboulet W, Hainaut E, Sebokova E, Conde-Knape K, Konkar A, DiMarchi RD, Tschöp MH. Finan B, et al. Among authors: dimarchi rd. Sci Transl Med. 2013 Oct 30;5(209):209ra151. doi: 10.1126/scitranslmed.3007218. Sci Transl Med. 2013. PMID: 24174327 Free article. Clinical Trial.
CNS-targeting pharmacological interventions for the metabolic syndrome.
Stemmer K, Müller TD, DiMarchi RD, Pfluger PT, Tschöp MH. Stemmer K, et al. Among authors: dimarchi rd. J Clin Invest. 2019 Aug 5;129(10):4058-4071. doi: 10.1172/JCI129195. eCollection 2019 Aug 5. J Clin Invest. 2019. PMID: 31380808 Free PMC article. Review.
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page